Waiting it Out: AutoGenomics Biding Time on IPO | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – AutoGenomics is still biding its time to proceed with an initial public offering, two years after filing its preliminary prospectus for the IPO.

The company last month amended its S-1 filing with the US Securities and Exchange Commission, suggesting that it might move on its plans to go public.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.